Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
0.5300
-0.0204 (-3.71%)
May 13, 2026, 9:44 AM EDT - Market open

Curis Revenue

Curis had revenue of $7.06M in the twelve months ending March 31, 2026, down -36.95% year-over-year. In the year 2025, Curis had annual revenue of $9.44M, down -13.43%.

Revenue (ttm)
$7.06M
Revenue Growth
-36.95%
P/S Ratio
2.33
Revenue / Employee
$393,458
Employees
24
Market Cap
21.19M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20259.44M-1.47M-13.43%
Dec 31, 202410.91M885.00K8.83%
Dec 31, 202310.02M-139.00K-1.37%
Dec 31, 202210.16M-487.00K-4.57%
Dec 31, 202110.65M-186.00K-1.72%
Dec 31, 202010.84M831.00K8.31%
Dec 31, 201910.00M-424.00K-4.07%
Dec 31, 201810.43M530.00K5.35%
Dec 31, 20179.90M2.37M31.50%
Dec 31, 20167.53M-351.00K-4.46%
Dec 31, 20157.88M-1.97M-19.96%
Dec 31, 20149.84M-5.16M-34.39%
Dec 31, 201315.00M-1.97M-11.61%
Dec 31, 201216.97M2.21M14.97%
Dec 31, 201114.76M-1.24M-7.73%
Dec 31, 201016.00M7.41M86.26%
Dec 31, 20098.59M223.32K2.67%
Dec 31, 20088.37M-8.02M-48.95%
Dec 31, 200716.39M1.45M9.73%
Dec 31, 200614.94M8.93M148.83%
Dec 31, 20056.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Celularity26.55M
Marker Therapeutics3.55M
OSR Holdings2.91M
Longeveron1.20M
VYNE Therapeutics570.00K
Exicure500.00K
Allarity Therapeutics320.00K
Revenue Rankings